Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Researchers Develop Stem Cell Therapies for Acute Lung Injury

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
An estimated 200,000 patients a year have acute respiratory failure in the U.S. and mortality is about 30 to 40 percent.

Matthay is working with Jae-Woo Lee, MD, Kathleen Liu, MD, MAS, PhD, and Carolyn Calfee, MD, MAS, associate professors of medicine and anesthesia, on developing cell-based therapies that he hopes “will make a major difference in reducing mortality in patients with acute respiratory distress syndrome, a major cause of acute respiratory failure in critically-ill patients.”

The research team’s experience translating these therapies from scientific concept to clinical practice is featured in a series of videos on LaunchPad, a new online resource for translational researchers that is managed by UCSF’s Clinical and Translational Science Institute (CTSI).

Moving a novel treatment into clinical trials requires an "Investigational New Drug" (IND) approval from the U.S. Food and Drug Administration (FDA). As Liu describes in the video, “Preparing the entire IND application for this project was going to be an enormous undertaking that I think we hadn’t really appreciated.”

Up until the IND process, the team of investigators had worked over many years on pre-clinical studies supporting proof-of-concept for a therapy using a type of stem cells, known as mesenchymal stem cells (MSCs), that could potentially treat injury to a variety of epithelial organs, including the lung and kidney.

Bone marrow-derived MSCs release proteins and lipids with potent anti-inflammatory effects as well as other growth factors that seem to enhance lung repair. Favorable pre-clinical data using these cells to treat injured lung tissue in vitro and in small and large animal models encouraged them to move into clinical trials. The struggle to implement this potentially life-saving therapy began with a search for clinical-grade MSCs. Liu credits “serendipity” and “six degrees of separation” for leading them to a collaborator at the University of Minnesota who creates the cells used in the team’s cell-based therapy.

The experience “speaks to how much of science is making connections with people who don’t do exactly what you do,” Liu says.

Identifying Gaps in the Development Plan

Matthay admits being naïve regarding the IND process, and following a pre-IND consultation, the investigators discovered that there was additional pre-clinical work to be done using a larger animal model. Matthay says that serendipity again came into play as a colleague at the University of Texas had the perfect model system available and agreed to carry out the experiments in collaboration.

Matthay and his colleagues have amassed a body of compelling pre-clinical data and secured funding to carry out phase two trials. However, the National Institutes of Health Heart, Lung and Blood Institute (NHLBI) that funded the Phase 2 trial does not cover the required Phase 1 trial focusing on safety. Furthermore, no clinical studies could be initiated without an approved IND.

It was at that point that the Catalyst Awards, another program managed by CTSI, “came to our rescue,” says Matthay. Liu echoes the sentiment, explaining that the Catalyst Awards and their advisor Dave Savello “were instrumental in helping us identify our knowledge gaps, and identify individuals and experts who could help us with those components of the IND that we simply don’t have the expertise to do.”

The Catalyst Awards provide expert feedback and funding to accelerate translational research into marketable products. Regulatory consultants helped Matthay and Liu develop a solid framework for their clinical trials, guiding them towards operationalizing the details of the design. This additional support led to the approval of an IND for the Phase 1 trial of this exciting new therapy, which enrolled its first patient here at UCSF in early July of this year.

UCSF's CTSI is a member of the Clinical and Translational Science Awards network funded through the National Center for Advancing Translational Sciences (grant Number UL1 TR000004) at the NIH Health. Under the banner of "Accelerating Research to Improve Health," CTSI provides a wide range of resources and services for researchers, and promotes online collaboration and networking tools such as UCSF Profiles.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
Friday, July 03, 2015
Grant Supports Creation of Patient-Derived Stem Cell Lines
Researchers have received a two-year, $600,000 grant from the National Institute on Aging to develop and study patient-derived stem cell lines.
Thursday, December 12, 2013
Prostate Cancer Stem Cells are a Moving Target
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
Friday, December 06, 2013
Researchers Change Cell Types by Flipping a Single Switch
New findings have identified a method for changing one cell type into another in a process called forced transdifferentiation.
Friday, December 06, 2013
Understanding a Protein’s Role in Familial Alzheimer’s
Researchers have used genetic engineering of human iPSC’s to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease (AD).
Monday, November 18, 2013
Researchers Un-Junking Junk DNA
A study shines a new light on molecular tools our cells use to govern regulated gene expression.
Wednesday, November 13, 2013
$100M gift launches Sanford Stem Cell Clinical Center
T. Denny Sanford has committed $100 million to the creation of the Sanford Stem Cell Clinical Center at the University of California, San Diego.
Wednesday, November 06, 2013
Grafted Limb Cells Acquire Molecular ‘Fingerprint’ of New Location
Findings further creation of regenerative therapies for humans.
Wednesday, October 30, 2013
From Mature Cells to Embryonic-Like Stem Cells
Bioengineers have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage.
Tuesday, October 22, 2013
Single Gene Mutation Linked to Neurological Disorders
Mutation could offer insights into Alzheimer’s, Parkinson’s and Huntigton’s Diseases.
Wednesday, October 16, 2013
Gene Repair Technique Could Have Many Applications
Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers have created an efficient way to target and repair defective genes.
Tuesday, August 13, 2013
Therapy Could Treat Breast Cancer that's Spread to Brain
Researchers have successfully combined cellular therapy and gene therapy in a mouse-model system to develop a viable treatment strategy for breast cancer that has spread to a patient's brain.
Tuesday, August 06, 2013
Scientists Streamline Production of Stem Cells
Researchers report a simple, easily reproducible RNA-based method of generating human induced pluripotent stem cells (iPSCs).
Friday, August 02, 2013
Stem Cell Discovery Furthers Research on Cell-Based Therapy and Cancer
Stem-cell researchers have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
Monday, July 22, 2013
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Restoring Vision with Stem Cells
Age-related macular degeneration (AMRD) could be treated by transplanting photoreceptors produced by the directed differentiation of stem cells, thanks to findings published today by Professor Gilbert Bernier of the University of Montreal and its affiliated Maisonneuve-Rosemont Hospital.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Tissue-Engineered Colon from Human Cells
A study by scientists at Children’s Hospital Los Angeles has shown that tissue-engineered colon derived from human cells is able to develop the many specialized nerves required for function, mimicking the neuronal population found in native colon.
Tension Helps Heart Cells Develop Normally in the Lab
Stanford engineers have uncovered the important role tension plays in growing heart cells out of the body.
Urine Excretion From Stem Cell-Derived Kidneys
Researchers report a strategy for enabling urine excretion from kidneys grown from stem cells.
Stem Cell Research Hints at Evolution of Human Brain
Researchers at UC San Francisco have succeeded in mapping the genetic signature of a unique group of stem cells in the human brain that seem to generate most of the neurons in our massive cerebral cortex.
The Final Word on STAP
Researchers fail to replicate STAP study; computational analysis reveals genomic inconsistency.
CRI Scientists See Through Bones
Findings uncover new details about blood-forming stem cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos